<DOC>
	<DOCNO>NCT01816997</DOCNO>
	<brief_summary>Evaluate effect rosuvastatin ( maybe high diabetogenic ) pravastatin ( seem protective ) glucose homeostasis biomarkers subject impair fast glucose .</brief_summary>
	<brief_title>The Statins Glucose Homeostasis Subjects With Impaired Fasting Glucose</brief_title>
	<detailed_description>Statin therapy effectively reduce cardiovascular event . However , trial data1 meta-analyses suggest statin also confer increased risk development diabetes . In order elucidate whether statin increase risk diabetes , investigator conduct study evaluate effect rosuvastatin ( maybe high diabetogenic ) pravastatin ( seem protective ) glucose homeostasis biomarkers subject impair fast glucose .</detailed_description>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Age 3570 year old 2 . Fasting blood glucose 100125 mg/dL 1 . A1C &gt; 7.0 % 2 . 2hr glucose OGTT &gt; 200 mg/dL 3 . Total cholesterol &gt; 280 mg/dL 4 . Previous diabetic history , coronary artery disease 5 . Allergy rosuvastatin parvastatin 6 . Baseline ALT 3 time UNL 7 . Serum Cr &gt; 2.0 mg/dL 8 . Pregnancy , breast feeding plan pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Statins</keyword>
	<keyword>Glucose homeostasis</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Impaired fasting glucose</keyword>
</DOC>